Opus Point Partners Management’s Axsome Therapeutics AXSM Stock Holding History

Opus Point Partners Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-120,150	Closed	-$415K	–	42
2018 Q3	$415K	Sell	120,150 -13,350	-10%	-$39.6K	0.99%	30
2018 Q2	$427K	Hold	133,500	–	–	0.93%	28
2018 Q1	$327K	Hold	133,500	–	–	0.64%	34
2017 Q4	$748K	Hold	133,500	–	–	0.65%	37
2017 Q3	$741K	Hold	133,500	–	–	0.66%	37
2017 Q2	$734K	Sell	133,500 -133,500	-50%	-$559K	0.67%	39
2017 Q1	$1.04M	Buy	+267,000	New	+$1.28M	0.77%	35

Other funds holding AXSM

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Opus Point Partners Management's AXSM Position: Q4 2018 in Review

Opus Point Partners Management sold out of Axsome Therapeutics (AXSM) in Q4 2018, closing a stake of 120,150 shares — an estimated $415K sold.

Opus Point Partners Management first reported a position in AXSM in Q1 2017 and held it in 7 quarters. The position peaked at $1.04M in Q1 2017. 35 funds tracked by Wall St. Rank hold AXSM as of Q4 2018.

Opus Point Partners Management reported no remaining Axsome Therapeutics position as of Q4 2018 after selling out during the quarter.
Opus Point Partners Management sold 120,150 Axsome Therapeutics shares in Q4 2018, an estimated $415K.
Opus Point Partners Management first reported a position in Axsome Therapeutics in Q1 2017 and held it in 7 quarters.
Opus Point Partners Management's Axsome Therapeutics position peaked at $1.04M in Q1 2017.
35 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2018.

Based on Opus Point Partners Management's 13F filing for Q4 2018, filed 14 Feb 2019.